Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

No reported Retained Earnings figures are available to summarize.

Retained Earnings history

Currency unavailable · from the balance sheet

No Retained Earnings data reported for this period type.

Retained Earnings vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Retained Earnings for LTGO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
COLLCollegium Pharmaceutical, Inc.Mar 2026-$86.63M USD+46.4%—5.2%
PCRXPacira BioSciences, Inc.Mar 2026-$196.41M USD+2.5%—16.3%
SCLXScilex Holding CompanyMar 2026-$965.06M USD-63.8%—328.7%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —+2.5%—16.3%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.